Figures & data
Table I. Characteristics of the study populations.
Table II. Prevalence of allergen-specific immunoglobulin E (IgE) (>0.35 kU/L) against at least one out of three allergens tested (cat, birch, and egg albumen) and high levels (≥100 kU/L) of total IgE in patients with type 1 diabetes and in control subjects in Finland.
Table III. Prevalence of allergen-specific IgE (>0.35 kU/L) against at least one out of three allergens tested (cat, birch, and egg albumen), reported frequency of allergic symptoms, and high levels (≥100 kU/L) of total IgE in patients with type 1 diabetes and in control subjects in Russian Karelia. Logistic regression model adjustment for the effect of age and gender was applied in the analyses.
Figure 1. Prevalence of hepatitis A virus (HAV) antibodies in Russian Karelian children with clinical type 1 diabetes or allergic sensitization detected by allergen-specific IgE (P = 0.016).
![Figure 1. Prevalence of hepatitis A virus (HAV) antibodies in Russian Karelian children with clinical type 1 diabetes or allergic sensitization detected by allergen-specific IgE (P = 0.016).](/cms/asset/0121d0d1-76e3-47ca-a219-c3334f053258/iann_a_481678_f0001_b.gif)
Table IV. Prevalence of allergen-specific IgE (>0.35 kU/L) against at least one out of three allergens tested (cat, birch, and egg albumen) in patients with type 1 diabetes and in control subjects in Russian Karelia in relation to diabetes-related HLA genotypes.